期刊文献+

β_2受体激动剂与抗胆碱能药物治疗儿童哮喘的评价 被引量:7

Systematic review ofβ2receptor agonists and anticholinergic drugs in children asthma
下载PDF
导出
摘要 目的评价β2受体激动剂、抗胆碱能药物以及β2受体激动剂联合抗胆碱能药物在治疗急诊儿童急性哮喘中的应用。方法搜索自建库至今Pubmed、Embase和中国科技期刊数据库关于抗胆碱能药物、β2受体激动剂在治疗儿童急性哮喘中的随机对照试验,对纳入的研究进行质量评价与数据提取,采用Revman 5.0.2软件进行统计分析。结果β2受体激动剂组在治疗失败率和接受治疗60min后1s用力呼气容积(FEV1)变化量占预计值的百分比方面明显优于抗胆碱能药物治疗组,OR及95%可信区间(95%CI)分别为2.27(95%CI:1.08-4.75)和12.6(95%CI:6.61-18.59),在住院率方面两组差异无统计学意义(P〉0.05),OR及95%CI为1.11(95%CI:0.66-1.86)。β2受体激动剂联合抗胆碱能药物组在治疗失败率、住院率和接受治疗60min后FEV1变化量占预计值的百分比方面明显优于抗胆碱能药物治疗组,OR及95%CI分别为3.67(95%CI:1.41-9.50)、2.28(95%CI:1.39-3.73)、10.65(95%CI:5.87-15.43)。结论β2受体激动剂以及β2受体激动剂联合抗胆碱能药物在治疗急诊儿童急性哮喘中的效果明显优于单独使用抗胆碱能药物。 Objective To evaluate the application ofβ2receptor agonists,anticholinergic drugs andβ2receptor agonists combined with anticholinergic drugs in children acute asthma.Methods The randomized controlled trials(RCTs)on the application ofβ2receptor agonists and anticholinergic drugs in children asthma were retrieved from the Pubmed,Embase and CJFD(from database establishment to now).The included RCTs were performed the quality evaluation and data extraction.The Revman 5.0.2software was adopted to conduct the statistical analysis.Results 14 RCTs involving 1028 patients were included.β2receptor agonists was significantly superior to the anticholinergic drugs in the aspects of the treatment failure rate and the percentage of FEV1 variation to the expected value at 60 min after treatment,ORand 95%CI were 2.27(95%CI:1.08-4.75)and 12.6(95%CI:6.61-18.59),the hospitalization rate had no statistical difference between the two groups(P〉0.05),ORand 95%CI were 1.11(95%CI:0.66-1.86).β2receptor agonists combined with anticholinergic drugs was significantly superior to the anticholinergic drugs treatment group in the aspects of the treatment failure rate,hospitalization rate and the percentage of FEV1 variation to the expected value at 60 min after treatment,ORand 95%CI were 3.67(95%CI:1.41-9.50),2.28(95%CI:1.39-3.73)and 10.65(95%CI:5.87-15.43).Conclusion β2receptor agonists andβ2receptor agonists combined with anticholinergic drugs have better efficacy on children acute asthma than single anticholinergic drugs.
作者 郭梅 荆安龙
出处 《检验医学与临床》 CAS 2014年第21期3008-3010,共3页 Laboratory Medicine and Clinic
关键词 Β2受体激动剂 抗胆碱能药物 β2受体激动剂联合抗胆碱能药物 儿童哮喘 急诊 β2 receptor agonists anticholinergic drugs β2receptor agonists combined with anticholinergic drugs children asthma
  • 相关文献

参考文献25

  • 1Pedersen SE, Hurd SS, Lemanske RF, et al. Global strate- gy for the diagnosis and management of asthma in chil- dren 5 years and younger[J]. Pediatr Pulmonol, 2011,46 (1) :1-17.
  • 2Frey U,Barben J, Hammer J. Obstructive air way disease in infants and children [J]. Ther Umsch 2013,70 ( 11 ) : 669-79.
  • 3Upham BD, Mollen CJ, Scarfone RJ, et al. Nebulized budes- onide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial [J]. Acad Emerg Med,2011,18(7):665-673.
  • 4Iramain R, Lepez-Herce J, Coronel J, et al. Inhaled salbu- tamol plus ipratropium in moderate and severe asthma cri- ses in children[J]. J Asthma,2011 ,48(3) :298-303.
  • 5Calvo GM,Calvo AM,Matin HF,et al. Is it useful to add an anticholinergic treatment to beta 2-adrenergic medica- tion in acute asthma attack? [J]. J Investig Allergol ClinImmunol 1998,8(1) : 30-34.
  • 6Cook JJ, Fergusson DM, Dawson KP. Ipratropium and fenoterol in the treatment of acute asthma[J]. Pharma- therapeutica, 1985,4(6) :383-386.
  • 7Guill MF, Maloney MJ, Durant RH. Comparison of in- haled metaproterenol, inhaled atropine sulfate, and their combination in treatment of children with acute asthma [J]. Ann Allergy,1987,59(5) :367-371.
  • 8Watson WT, Becket AB, Simons FE. Comparison of iprat- ropium solution,fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma[J]. J Allergy Clin Immunol, 1988,82 (6) : 1012-1018.
  • 9Ducharme FM,Davis GM. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma[J]. J Pediatr, 1998,133 (4) : 479-485.
  • 10Schuh S, Johnson DW, Callahan S, et al. Efficacy of fre- quent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma [J]. J Pediatr,1995,126(4) :639-645.

同被引文献67

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部